Pinpointing and targeting novel drivers of pancreatic cancer progression and metastasis using TRAP-seq. (#149)

12:45 PM

Michael Trpceski

Lunch & Poster Viewing (Odd Numbers)

Investigating novel matrisomal targets in PC to reduce fibrosis and improve standard-of-care chemotherapy. (#155)

12:45 PM

Jessie Zhu

Lunch & Poster Viewing (Odd Numbers)

Inhibition of the NPY signalling axis as a novel therapeutic option in Pancreatic Cancer. (#38)

12:35 PM

Cecilia Chambers

Concurrent Session - Cancer Biology

Targeting subcellular JNK activity in pancreatic cancer (#107)

12:45 PM

Antonia L Cadell

Lunch & Poster Viewing (Odd Numbers)

Temporal proteomic profiling reveals Nidogen-2 as a new stromal co-target in pancreatic cancer (#138)

1:00 PM

Brooke Pereira

Lunch & Poster Viewing (Even Numbers)

Putting the brakes on CDK4/6 inhibitor resistance in estrogen receptor positive breast cancers by harnessing the potential of CDK1 inhibition (#35)

12:05 PM

Sarah Alexandrou

Concurrent Session - Cancer Biology

SPEAR: A Phase 2, Open-label, Single-arm Monotherapy Trial of Sulfasalazine in Pancreatic Adenocarcinoma – Trial in Progress  (#321)

12:45 PM

Omali Pitiyarachchi

Lunch & Poster Viewing (Odd Numbers)